Joan C. Hendricks
Joan C. Hendricks served on the faculty of the University of Pennsylvania School of Veterinary Medicine for more than 20 years. From 2006 to 2016, Dr. Hendricks was the Gilbert S. Kahn Dean of Veterinary Medicine at the School of Veterinary Medicine. In 2001 she was named the Henry and Corinne R. Bower Professor of Small Animal Medicine, the first woman to be named to an endowed professorship at the school. Dr. Hendricks also served as chief of critical care in the Department of Clinical Studies at Philadelphia, she was the founding director of the Veterinary Clinical Investigation Center (VCIC) at the school, and she held a secondary appointment as professor in the Department of Medicine at Penn Medicine. She is a recognized expert in the field of sleep and sleep disorders and has, for decades, studied the physiology and anatomy of sleep and an animal model of sleep apnea (the English bulldog). She later on switched to using Drosophila as a model to study sleep and sleep disorders. Dr. Hendricks has a BS in biology and psychology from Yale University and a VMD and PhD from the University of Pennsylvania. Dr. Hendricks currently is on terminal sabbatical and will retire effective August 1, 2019.
Kathrin Herrmann is a veterinarian and assistant scientist at the Center for Alternatives to Animal Testing (CAAT) at the Johns Hopkins Bloomberg School of Public Health in Baltimore, Maryland. At CAAT-US as well as CAAT-Europe (based at the University of Konstanz, Germany), she coordinates the Refinement Program. During her veterinary training, which involved studies in Berlin, Germany and Zürich, Switzerland, and clinical trainings at Cornell University, USA, Massey University, NZ, and University of Pretoria, SA, Kathrin was engaged in many animal protection issues. Animal experimentation and the 3Rs have been her primary focus since she became a research fellow at the Animals Scientific Procedures Inspectorate in Berlin (2007-2017). After a 4-year residency program, Kathrin became a veterinary specialist of animal welfare and ethics in Germany in 2014. Since 2016, she is an accredited European Specialist in Animal Welfare Science, Ethics and Law with the European College of Animal Welfare and Behavioural Medicine. For her PhD studies (2012-2018), supervised by Professor Paul Flecknell, she reviewed German animal research applications to determine whether all existing refinement measures were being proposed as a means of reducing animal suffering to the absolute minimum. Her other interests relate to advocating for openness and public engagement in animal experimentation and for humane education. Kathrin also raises awareness of the important role veterinarians should play in animal protection. She is the initiator and co-editor of the forthcoming book “Animal Experimentation: Working Towards a Paradigm Change” (Brill, Vol. 22), which features 51 authors who review current animal use in science, present new and innovative non-animal approaches to address urgent scientific questions, and offer a roadmap towards replacement. "Animal Experimentation: Working Towards a Paradigm Change" will be available through open access in early 2019.
Jonathan Kimmelman is the James McGill Professor in the Biomedical Ethics Unit/Social Studies of Medicine of McGill University. He has cross appointments in Experimental Medicine, Epidemiology, Biostatistics and Occupational Health, and Human Genetics. Kimmelman holds a PhD in molecular biophysics and biochemistry from Yale University, and joined McGill in 2005. His research revolves around the ethical, social and policy dimensions of translational research. He received the Institute of Genetics Maud Menten New Investigator Prize, a Canadian Institutes of Health Research (CIHR) New Investigator Award (2008) and a Friedrich Bessel-Humboldt Award (2014). Kimmelman chaired the ethics committee of the American Society of Gene and Cell Therapy, 2008-2010, and International Society of Stem Cell Research (2014-2016). He also served on the CIHR Stem Cell Oversight Committee, serves on several DSMBs of the U.S. NIH, and has been a member of three National Academies committee reports. His book, Gene Transfer and the Ethics of First-in-Human Trials: Lost in Translation, was published by Cambridge University Press. In 2018, he was named as a Hastings Center Fellow. Kimmelman's research centers on the ethical, social, and policy challenges in testing novel medical technologies in human beings ("translational clinical research"). Current projects are investigating risk, prediction, validity, and knowledge value across the trajectory of drug development. Another set of projects is pursuing alternative frameworks and understandings concerning the role and content of clinical research ethics. Kimmelman directs the Studies of Translation, Ethics, and Medicine (STREAM) research group.
Lewis B. Kinter
Lewis B. Kinter is currently President and Principal Scientist at GLP Scientific Consulting, Unionville, Pennsylvania. He has been engaged in pharmaceutical, biological, and medical device research and development for over 30 years and is an internationally recognized expert in nonclinical R&D. Dr. Kinter received his BS in biology at Union College (1973) and his doctorate in medical physiology from Harvard University (1978). From 1981 to 2014 he held positions of increasing responsibility in biomedical R&D with Smith Kline & French, SmithKline Beecham, Sterling Winthrop, Nycomed Amersham, Astra Merck, and AstraZeneca. Dr. Kinter is a Diplomate of the American Board of Toxicology, Fellow of the Academy of Toxicological Sciences, Professor of Pharmacology & Toxicology (Adjunct) at Michigan State University, and has authored over 100 research manuscripts and book chapters in basic and applied physiology, pharmacology, and toxicology. Dr. Kinter serves in leadership capacities on several boards of professional scientific and charitable organizations.
Sarah L. Lathrop
Sarah L. Lathrop, Professor of Pathology and Office of the Medical Investigator (OMI) Epidemiologist, received her undergraduate education at Colorado State University and earned her DVM from the University of Minnesota College of Veterinary Medicine. She practiced veterinary medicine in Cortez, Colorado, and then completed a PhD in veterinary preventive medicine at Ohio State University. Dr. Lathrop served a two-year post-doctoral fellowship at the Centers for Disease Control and Prevention as an Epidemic Intelligence Service Officer, studying vector-borne infectious diseases such as plague, tularemia, and dengue. After a brief stint in industry overseeing clinical vaccine trials, Dr. Lathrop joined OMI in 2003 to conduct epidemiological studies using medical examiner data. She also serves as the Principal Investigator for the FoodNet portion of New Mexico's Emerging Infections Program. Her research interests include the intersection of forensic pathology and epidemiology, public health topics such as trends in violent deaths and sudden unexpected infant death investigation, as well as investigation of foodborne infections.
Vince Mendenhall, an internationally renowned experimental surgeon, is known for his innovative surgical techniques, rigorous protocols, and deep expertise in medical device development. He is a world leader in translating scientific discovery to clinical application. Dr. Mendenhall received his Doctor of Veterinary Medicine degree and his doctorate in experimental surgery from Colorado State University. After receiving his degrees, he was employed at 3M Company, where he developed their department of surgical research with an emphasis on medical device development. He then worked at Primedica/Charles River Laboratories from 1992 to 2008 where he averaged over 50 surgical studies a year. Dr. Mendenhall joined Wake Forest Innovations in 2008. The results of his development work throughout the years have been presented at 146 national and international peer-reviewed meetings, published in 10 book chapters and 21 referred publications. In his career, he has developed many new surgical models for experimental medicine, medical device development, safety pharmacology, pharmacokinetics, and specialized toxicology. As a preclinical surgeon, Dr. Mendenhall strictly replicates the clinical experience using surgical techniques and innovative procedures to reduce inflammation, prevent infection, and promote wound healing. By attending to animal models with the same care used in clinical trials, his work significantly enhances the validity of preclinical research results. He is currently a private consultant.
David M. Powell
David M. Powell joined the Saint Louis Zoo as Director of Research in August 2016. He is responsible for oversight of behavioral, reproductive, and endocrine research, as well as some visitor studies research. Prior to coming to Saint Louis, David was Associate Curator of Mammals at the Wildlife Conservation Society's Bronx Zoo in New York for 12 years, where he developed a strong background in captive mammal management and husbandry. David received his Ph.D. from the University of Maryland for his studies of behavior and reproductive biology in the feral horses on Assateague Island. David did his post doctoral studies at the Smithsonian Institution's National Zoological Park in the Department of Conservation Biology studying giant panda behavior in U.S. and Chinese zoos for four years. David also worked at Zoo Atlanta from 1988-1993 in various roles, including animal keeper, animal diet technician, and research intern. He is actively involved in the Association of Zoos and Aquariums (AZA) professional activities including serving on Taxon Advisory Group steering committees, managing breeding programs and serving on the AZA Animal Welfare and Wildlife Conservation & Management Committee. He currently serves on the Research Review Committee of the Saint Louis Zoo. Previously, he served on the IACUC of Lehman College (2008-2014) and the National Zoo, Rock Creek Campus (2004). David's research has focused on a number of species and topics over the years in zoos and in the field. Topics of study have included dominance in animal societies, reproductive competition, maternal behavior, impacts of environmental enrichment and other husbandry practices on behavior, animal welfare, characterization of animal personality and personality measurement methods, affective impact of zoo exhibits on visitors, and studies of animal care staff attitudes about population management practices.